Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 48

Cited In for PubMed (Select 10784639)

1.

Lipid Signaling in Tumorigenesis.

Liu R, Huang Y.

Mol Cell Pharmacol. 2014 Jan 1;6(1):1-9.

2.

SMK-17, a MEK1/2-specific inhibitor, selectively induces apoptosis in β-catenin-mutated tumors.

Kiga M, Nakayama A, Shikata Y, Sasazawa Y, Murakami R, Nakanishi T, Tashiro E, Imoto M.

Sci Rep. 2015 Feb 2;5:8155. doi: 10.1038/srep08155.

3.

The evolution of colorectal cancer genetics-Part 1: from discovery to practice.

Schlussel AT, Gagliano RA Jr, Seto-Donlon S, Eggerding F, Donlon T, Berenberg J, Lynch HT.

J Gastrointest Oncol. 2014 Oct;5(5):326-35. doi: 10.3978/j.issn.2078-6891.2014.069. Review.

4.

Multiple roles of toll-like receptor 4 in colorectal cancer.

Yesudhas D, Gosu V, Anwar MA, Choi S.

Front Immunol. 2014 Jul 15;5:334. doi: 10.3389/fimmu.2014.00334. eCollection 2014. Review.

5.

Identification of previously unrecognized FAP in children with Gardner fibroma.

Vieira J, Pinto C, Afonso M, do Bom Sucesso M, Lopes P, Pinheiro M, Veiga I, Henrique R, Teixeira MR.

Eur J Hum Genet. 2015 May;23(5):715-8. doi: 10.1038/ejhg.2014.144. Epub 2014 Jul 30.

PMID:
25074465
6.

Targeting mTOR network in colorectal cancer therapy.

Wang XW, Zhang YJ.

World J Gastroenterol. 2014 Apr 21;20(15):4178-88. doi: 10.3748/wjg.v20.i15.4178. Review.

7.

Mutational analysis and clinical correlation of metastatic colorectal cancer.

Russo AL, Borger DR, Szymonifka J, Ryan DP, Wo JY, Blaszkowsky LS, Kwak EL, Allen JN, Wadlow RC, Zhu AX, Murphy JE, Faris JE, Dias-Santagata D, Haigis KM, Ellisen LW, Iafrate AJ, Hong TS.

Cancer. 2014 May 15;120(10):1482-90. doi: 10.1002/cncr.28599. Epub 2014 Feb 5.

8.

Targeting the LKB1 tumor suppressor.

Zhao RX, Xu ZX.

Curr Drug Targets. 2014 Jan;15(1):32-52. Review.

9.

Candidate serum biomarkers for early intestinal cancer using 15N metabolic labeling and quantitative proteomics in the ApcMin/+ mouse.

Ivancic MM, Huttlin EL, Chen X, Pleiman JK, Irving AA, Hegeman AD, Dove WF, Sussman MR.

J Proteome Res. 2013 Sep 6;12(9):4152-66. doi: 10.1021/pr400467c. Epub 2013 Aug 8.

10.

PIK3CA and APC mutations are synergistic in the development of intestinal cancers.

Deming DA, Leystra AA, Nettekoven L, Sievers C, Miller D, Middlebrooks M, Clipson L, Albrecht D, Bacher J, Washington MK, Weichert J, Halberg RB.

Oncogene. 2014 Apr 24;33(17):2245-54. doi: 10.1038/onc.2013.167. Epub 2013 May 27.

11.

Heavy ion radiation exposure triggered higher intestinal tumor frequency and greater β-catenin activation than γ radiation in APC(Min/+) mice.

Datta K, Suman S, Kallakury BV, Fornace AJ Jr.

PLoS One. 2013;8(3):e59295. doi: 10.1371/journal.pone.0059295. Epub 2013 Mar 21.

12.

Downregulation of DLC-1 gene by promoter methylation during primary colorectal cancer progression.

Peng H, Long F, Wu Z, Chu Y, Li J, Kuai R, Zhang J, Kang Z, Zhang X, Guan M.

Biomed Res Int. 2013;2013:181384. doi: 10.1155/2013/181384. Epub 2012 Dec 23.

13.

Expression Profiling of Proliferation and Apoptotic Markers along the Adenoma-Carcinoma Sequence in Familial Adenomatous Polyposis Patients.

Wang J, El-Masry N, Talbot I, Tomlinson I, Alison MR, El-Bahrawy M.

Gastroenterol Res Pract. 2013;2013:107534. doi: 10.1155/2013/107534. Epub 2013 Feb 13.

14.

PTEN loss and HOXA10 expression are associated with ovarian endometrioid adenocarcinoma differentiation and progression.

Tanwar PS, Kaneko-Tarui T, Lee HJ, Zhang L, Teixeira JM.

Carcinogenesis. 2013 Apr;34(4):893-901. doi: 10.1093/carcin/bgs405. Epub 2012 Dec 31.

15.

Using components of the vitamin D pathway to prevent and treat colon cancer.

Stubbins RE, Hakeem A, Núñez NP.

Nutr Rev. 2012 Dec;70(12):721-9. doi: 10.1111/j.1753-4887.2012.00522.x. Epub 2012 Oct 12. Review.

16.

A De Novo Germline APC Mutation (3927del5) in a Patient with Familial Adenomatous Polyposis: Case Report and Literature Review.

Zeichner SB, Raj N, Cusnir M, Francavilla M, Hirzel A.

Clin Med Insights Oncol. 2012;6:315-23. doi: 10.4137/CMO.S10178. Epub 2012 Aug 29.

17.

Role of calcium, vitamin D, and the extrarenal vitamin D hydroxylases in carcinogenesis.

Höbaus J, Thiem U, Hummel DM, Kallay E.

Anticancer Agents Med Chem. 2013 Jan;13(1):20-35. Review.

18.

A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on the APC/β-catenin pathway in the normal mucosa of colorectal adenoma patients.

Ahearn TU, Shaukat A, Flanders WD, Rutherford RE, Bostick RM.

Cancer Prev Res (Phila). 2012 Oct;5(10):1247-56. doi: 10.1158/1940-6207.CAPR-12-0292. Epub 2012 Sep 10.

19.

Transcriptome profiling of the cancer, adjacent non-tumor and distant normal tissues from a colorectal cancer patient by deep sequencing.

Wu Y, Wang X, Wu F, Huang R, Xue F, Liang G, Tao M, Cai P, Huang Y.

PLoS One. 2012;7(8):e41001. doi: 10.1371/journal.pone.0041001. Epub 2012 Aug 8.

20.

Hereditary aspects of colon cancer.

Wills JC, Burt RW.

Ochsner J. 2002 Summer;4(3):129-38.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk